Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pigmentation Disorder Treatment Market
Pigmentation Disorder Treatment Market Trends
- Report ID: GMI8528
- Published Date: Mar 2024
- Report Format: PDF
Pigmentation Disorder Treatment Market Trends
- The increasing demand for cosmetic procedures especially focusing on skin rejuvenation and achieving an even skin tone, is expected to drive significant growth in the market.
- Moreover, pigmentation disorders such as melasma and post-inflammatory hyperpigmentation are among the conditions commonly addressed through aesthetic dermatology treatments. This expansion of aesthetic dermatology services has contributed to the overall growth of the pigmentation disorders treatment market.
Frequently Asked Questions (FAQ) :
The global pigmentation disorders treatment market was valued at USD 7.1 billion in 2023 and is expected to reach USD 11.6 billion by 2032, backed by the increasing prevalence of pigmentation disorders, such as vitiligo, melasma, and post-inflammatory hyperpigmentation among others.
The drugs segment accounted USD 4 billion in 2023 and will record notable demand through 2032, owing to increased R&D activities and product launches by major players in the industry.
In 2023, North America pigmentation disorders treatment market share was around 42.2%, and is expected to show impressive growth through 2032, attributed to high healthcare expenditure, alongside advanced medical infrastructure in the region.
AbbVie Inc., Candela Corporation, Cipher Pharmaceuticals Inc., Galderma, GlaxoSmithKline (GSK), Incyte, L'Oréal Paris, Novartis AG, Pfizer Inc., Pierre Fabre Group, and Shiseido Company Limited among others.
Pigmentation Disorder Treatment Market Scope
×
Get a free sample of
Pigmentation Disorder Treatment Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below